Media Releases

8 July, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that, according
to the 2019 Journal Citation Reports (JCR), Pathology, the RCPA’s official journal, has increased
its impact factor to 3.744, which is an increase of 18.4% on the previous year. In addition,   the
overall   ranking   of Pathology has increased,   soaring five places    to be listed 16 out of 78
pathology titles.

6 July, 2020

The Royal College of Pathologists of Australasia (RCPA) strongly recommends that individuals continue to visit their GP to vaccinate children in accordance with the National Immunisation Program (NIP) Schedule in Australia and the National Immunisation Schedule in New Zealand. This year, for the first time, all children aged six months to five years of age are eligible to receive a free influenza vaccine under the NIP Schedule.

9 June, 2020

As social distancing measures begin to ease, the Royal College of Pathologists of Australasia (RCPA) explains that maintaining high levels Polymerase Chain Reaction (PCR) tests for COVID-19, and an effective public health approach, is key to managing the risk of new outbreaks in Australia and New Zealand.

29 May, 2020

The Royal College of Pathologists of Australasia (RCPA) supports the use of self-collection for COVID-19 Polymerase Chain Reaction (PCR) tests, when performed under the direction of a medical professional. During a recent trial, self-collected specimens were shown to be an acceptable alternative to specimens collected by healthcare workers and will therefore help to meet demand for COVID-19 testing in the community.

25 May, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that genetic tests to identify heritable mutations, which increase the risk of developing colorectal and endometrial cancer, are now available on the Medicare Benefits Schedule (MBS). This addition to the MBS follows an application by the RCPA to the Medical Services Advisory Committee (MSAC).

11 May, 2020

The Royal College of Pathologists of Australasia (RCPA) is pleased to announce that genetic testing for heritable mutations associated with Familial Hypercholesterolemia (FH) is now listed on the Medicare Benefits Schedule (MBS). This addition to the MBS follows an application by the RCPA to the Medical Services Advisory Committee (MSAC).

22 April, 2020

A nationwide collaboration to deliver consistently high levels of diagnostic pathology testing for COVID-19 has been pivotal in minimising the impact of COVID-19 in New Zealand. The Royal College of Pathologists of Australasia (RCPA) advises that this high level of quality testing, combined with the community adhering to the Government's guidelines, is essential for managing the outbreak.

15 April, 2020

People who need regular pathology tests to monitor and treat health conditions should keep up with their tests and medical appointments to avoid unnecessary illness or complications.

10 April, 2020

The Royal College of Pathologists of Australasia (RCPA) strongly urges individuals to attend important medical appointments and have pathology tests performed. Despite coronavirus control measures being in place, it is essential that individuals do not delay having these tests in order to avoid poor health outcomes, potential hospitalisation and increased morbidity/mortality.

24 March, 2020

Due to a limited supply, the Royal College of Pathologists of Australasia (RCPA) is calling for all clinicians, GPs and healthcare providers to conserve the utilisation of all swabs, by limiting any unnecessary or non-urgent testing, such as for chronic leg ulcers.

Dr Michael Dray – President of the Royal College of Pathologists of Australasia said, “It is essential that the use of all swabs is conserved to critical testing only. Currently, swabs should only be utilised for the testing of COVID-19 where they meet testing criteria, and for other urgent conditions.


Displaying results 1 - 10 of 52

Page last updated:

Copyright © 2020 RCPA. All rights reserved.

Top